News
Keep up to date with our latest news
ISOQOL 30th Annual Conference take-aways
The International Society for Quality of Life Research (ISOQOL) 30th Annual Conference took place last month in Calgary, providing the opportunity for researchers, healthcare professionals, industry representatives, and patient research partners to explore the use of...
ISPOR EU 2023
ISPOR Europe is on the horizon and we’ll be exhibiting four posters at stand C2-027, and Mark Larkin, CEO, will be speaking at an educational symposium. This year’s conference will focus on the role of health economics and outcomes research science in shaping policy –...
30 Years of ISOQOL: Quality of Life – making it relevant
The 30th annual ISOQOL conference is taking place in Calgary, Canada, on 18th - 21st October. This year, the theme will be “Quality of Life – making it relevant”, with a focus on identifying the many barriers that limit the use of patient-reported outcomes in...
MyRealWorld MG study announcement
The MyRealWorld MG study, a longitudinal digital observational study exploring the impact of myasthenia gravis (MG) from the patient perspective, has been run by Vitaccess on behalf of argenx since December 2019. Since then, over 2,400 adults with MG residing across...
American Health Research study launch
We are delighted to announce that this month, American Health Research, in collaboration with Vitaccess, have launched the investigator-initiated AHR CB study. The study is designed to help researchers learn how Mucinex® could be used as a long-term treatment to...
How to successfully implement a digital real-world study
How to successfully implement a digital real-world study. Approaches in rare disease and oncology On 21st February, we hosted the 14th webinar in the “Keeping it real” series. Mark Larkin, CEO and Laura Day, Associate Director, Analytics, discussed how to...
Join our ISPOR short course
Join Dr Mark Larkin, Dr Catherine Bottomley, and Dr Casey Quinn for the virtual ISPOR short course on Digital Real-World Evidence Generation Approaches in Rare Diseases and Oncology.The course is designed to provide a good understanding of how to plan and undertake...
KIR#12 – Patient engagement and retention in real-world studies
Sam Llewellyn, Senior Consultant, and Dr Mark Larkin, CEO and Founder of Vitaccess, presented examples of real-world studies where patient retention strategies have been used, resulting in strong engagement. Suitable for all evidence generation stakeholders, they...
ISPOR Europe 2022
This year’s conference theme is “Collaborating across borders: building and using evidence to enable access” – a perfect opportunity to discuss our capabilities with you and explore how we can help you launch and run real-world studies. Get in touch to book a meeting...
KIR #11 – Capturing and quantifying micro-moments in RWE research
On September 28, we hosted the latest webinar in our “Keeping it real” series. Sally Vincent, Senior Consultant in Patient-Centered Outcomes, and Dr Mark Larkin, Founder and CEO of Vitaccess, discussed capturing, characterizing, and quantifying micro-moments in...
ISOQOL Annual Conference 2022 – attend our workshop
The 29th annual ISOQOL conference is taking place in Prague, October 19–22. This year, the theme will be “Redefining boundaries – breaking new ground in patient-centered outcomes research”. We'll be there, will you?We will be hosting a workshop on “Balancing...
KIR #10 – Real-world data for medical device access
On August 24, we hosted the latest webinar in our “Keeping it real” series. Steven Haken, Founder and CEO of Odelle Technology, Claire Edwards, Consultant at Odelle Technology, and Dr Mark Larkin, Founder and CEO of Vitaccess, discussed using prospectively generated...
Keeping it real #9 – Patient engagement in the publication of real-world evidence
On July 20, we hosted the latest webinar in our “Keeping it real” series – the first in partnership with Envision Pharma Group since we joined forces earlier this year. Dr Dawn Lobban, Global Lead, Patient Partnerships at Envision the Patient (part of the Envision...
Keeping it real #8 – How to avoid obstacles to digital RWE analytics
On June 21, we hosted our latest “Keeping it real” webinar – on how to avoid obstacles to digital RWE analytics. Dr Casey Quinn, Chief Research Officer, and Amber Kudlac, Associate Director, discussed their experiences of these obstacles and barriers, and, crucially,...
MyRealWorld™ MG reaches over 2,000 participants!
As of late April, the MyRealWorld™ MG (MRW MG) study has reached over 2,000 participants! Study participants are based in Italy, the USA, Spain, Belgium, Canada, Japan, Germany, the UK, France, and Denmark. We would like to sincerely thank all participants, patient...
It’s ISPOR 2022 – let’s talk!
During ISPOR 2022, speak to the Vitaccess team about your real-world evidence projects. We’re here to help. We are regulars at the annual ISPOR conference, with a number of posters and workshops presented in the past. We’re not attending the event in May but hope to...
Keeping it real #7 – Diagnosis validation in patient-centered research
On May 10, we hosted the 7th webinar in the “Keeping it real” series. Dr Catherine Bottomley, Chief Scientific Officer, and Sam Llewellyn, Senior Consultant, discussed diagnosis validation in patient-centered research – specifically, alternatives to clinician-led...
MyRealWorld™ MG: Study launch in Denmark
On March 23, 2022, the MyRealWorld™ MG (MRW MG) study expanded to include Denmark in its list of study countries. This means that the digital real-world evidence study, which has been ongoing since December 2019, now operates across nine countries: the US, Canada,...
